Quantcast
Last updated on February 13, 2012 at 7:03 EST

Analyse The Top 10 Specialty Pharmaceutical Companies

March 8, 2007

Research and Markets (http://www.researchandmarkets.com/reports/c51758) has announced the addition of the new Frost & Sullivan Report “Analysis of Top 10 Specialty Pharmaceutical Companies” to their offering.

Research Overview

This Frost & Sullivan research service, titled Analysis of Top 10 Specialty Pharmaceutical Companies, provides an overview and analysis of key growth drivers, strengths, weakness, opportunities and threats with company profiles. In this research, Frost & Sullivan’s expert analysts thoroughly examine the top 10 specialty pharmaceutical companies.

Market Sectors

Frost & Sullivan’s expert analysts thoroughly examine the following market sectors in this research:

Specialty Pharmaceuticals

Technologies

The following technologies are covered in this research:

Generic Drugs

Branded Drugs

Market Overview

Mergers and Acquisitions Likely to Consolidate Market

The specialty pharmaceutical market is witnessing consolidation across various tiers of competition, creating larger and more competitive market participants with sufficient resources to compete with “Big-Pharma” companies. Specialty pharmaceutical companies focus on markets with signficant unmet medical need. However, these markets are not as large as the area’s of focus of “Big Pharma” companies. With dwindling pipelines and generic threats to blockbuster drugs, “Big Pharma” companies are likely to focus on these markets and compete with specialty pharmaceutical companies. Hence, the market is witnessing consolidation to compete with these “Big Pharma” companies.

Analysis of Top 10 Specialty Pharmaceutical Companies provides an overview and analysis of the top 10 specialty pharmaceutical companies in U.S. This research includes detailed analysis of key growth drivers, strengths, weakness, opportunities and threats that have been evaluated following extensive interviews with market participants.

Companies Mentioned:

Teva Pharmaceutical Industries Ltd

Forest Laboratories Inc

Allergan Inc

Watson Pharmaceuticals Inc

Shire Pharmaceuticals Group

King Pharmaceuticals Inc

Andrx Corporation

Barr Pharmaceuticals Inc

Cephalon Inc

Endo Pharmaceuticals

For more information, visit http://www.researchandmarkets.com/reports/c51758